Costa SD - Search Results

1

Acute hepatic failure following monotherapy with sunitinib for ovarian cancer.

Taran A, Ignatov A, Smith B, Costa SD, Bischoff J. Taran A, et al. Among authors: costa sd. Cancer Chemother Pharmacol. 2009 Apr;63(5):971-2. doi: 10.1007/s00280-008-0814-7. Epub 2008 Aug 21. Cancer Chemother Pharmacol. 2009. PMID: 18716778 No abstract available.

2

Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.

Taran A, Ignatov A, Smith B, Bischoff J, Costa SD. Taran A, et al. Among authors: costa sd. Am J Obstet Gynecol. 2008 Nov;199(5):e6-8. doi: 10.1016/j.ajog.2008.07.045. Am J Obstet Gynecol. 2008. PMID: 18984073

3

Ovarian cyst torsion and extreme ovarian stimulation in a premenopausal patient treated with tamoxifen for ductal carcinoma in situ of the breast.

Taran A, Eggemann H, Costa SD, Smith B, Bischoff J. Taran A, et al. Among authors: costa sd. Am J Obstet Gynecol. 2006 Oct;195(4):e5-6. doi: 10.1016/j.ajog.2006.06.073. Am J Obstet Gynecol. 2006. PMID: 17000228

4

Interval between port catheter flushing can be extended to four months.

Ignatov A, Ignatov T, Taran A, Smith B, Costa SD, Bischoff J. Ignatov A, et al. Among authors: costa sd. Gynecol Obstet Invest. 2010;70(2):91-4. doi: 10.1159/000294919. Epub 2010 Mar 11. Gynecol Obstet Invest. 2010. PMID: 20224280

5

Platelet Count After Chemotherapy is a Predictor for Outcome for Ovarian Cancer Patients.

Eggemann H, Ehricke J, Ignatov T, Fettke F, Semczuk A, Costa SD, Ignatov A. Eggemann H, et al. Among authors: costa sd. Cancer Invest. 2015 May;33(5):193-6. doi: 10.3109/07357907.2015.1020384. Epub 2015 Apr 1. Cancer Invest. 2015. PMID: 25831456

6

BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC.

Ignatov T, Poehlmann A, Ignatov A, Schinlauer A, Costa SD, Roessner A, Kalinski T, Bischoff J. Ignatov T, et al. Among authors: costa sd. Breast Cancer Res Treat. 2013 Sep;141(2):205-12. doi: 10.1007/s10549-013-2693-9. Epub 2013 Sep 13. Breast Cancer Res Treat. 2013. PMID: 24026861

7

Adjuvant therapy for early breast cancer.

Costa SD, Bischoff J. Costa SD, et al. N Engl J Med. 2007 Mar 22;356(12):1268-9. doi: 10.1056/NEJMc063408. N Engl J Med. 2007. PMID: 17377168 No abstract available.

8

BRCA1 promoter methylation is a marker of better response to platinum-taxane-based therapy in sporadic epithelial ovarian cancer.

Ignatov T, Eggemann H, Costa SD, Roessner A, Kalinski T, Ignatov A. Ignatov T, et al. Among authors: costa sd. J Cancer Res Clin Oncol. 2014 Sep;140(9):1457-63. doi: 10.1007/s00432-014-1704-5. Epub 2014 May 14. J Cancer Res Clin Oncol. 2014. PMID: 24825122

9

Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis.

Eggemann H, Bernreiter AL, Reinisch M, Loibl S, Taran FA, Costa SD, Ignatov A. Eggemann H, et al. Among authors: costa sd. Br J Cancer. 2019 Feb;120(3):301-305. doi: 10.1038/s41416-018-0369-2. Epub 2019 Jan 17. Br J Cancer. 2019. PMID: 30655614 Free PMC article.

10

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients.

Eggemann H, Ignatov A, Smith BJ, Altmann U, von Minckwitz G, Röhl FW, Jahn M, Costa SD. Eggemann H, et al. Among authors: costa sd. Breast Cancer Res Treat. 2013 Jan;137(2):465-70. doi: 10.1007/s10549-012-2355-3. Epub 2012 Dec 9. Breast Cancer Res Treat. 2013. PMID: 23224235 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters